ADAP Message Board Post 9876878 | Adaptimmune Therapeutics...
home / stock / adap / adap message board
Breakthewallsdown23
(investorshub)
Posted on: Apr/30/2023 17:33:59
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171805778
ASCO The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly
News, Short Squeeze, Breakout and More Instantly...
Adaptimmune Therapeutics plc Company Name:
ADAP Stock Symbol:
Market:
-
Company remains focused on launching afami-cel later this year with a PDUFA date of August 4 th and developing its broader sarcoma franchise Update on afami-cel launch plans to be provided at the April 18 th Investor Day Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. -...
-
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company's pivotal Phase 2 data with ...
-
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial r...